GEIST:UPC Searchengine

ORD_3985/2025

Newyu,Inc., Abbott Laboratories, Abbott Laboratories A/S, Abbott Scandinavia Aktiebolag, Abbott Diabetes Care Inc., Abbott GmbH, Abbott Logistics B.V., Abbott S.r.l., Abbott Gesellschaft m.b.H., Abbott Oy, Abbott Diagnostics GmbH, Abbott, Abbott B.V.

Datum
2025-01-24
Kammer
Luxembourg (LU)
Verfahrensart
Application Rop 265
Sprache
EN

Metadaten

Fall-IDORD_3985-2025-0d775c636b93
Aktenzeichen
RegisterzeichenORD_3985/2025
EntscheidungsreferenzORD_3985/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 24 January 2025 Withdrawal pursuant to R. 265 RoP and Application for reimbursement of Court fees (R. 370.9 RoP) HEADNOTES: - An application to withdraw an action pursuant to R.265 RoP can also be filed in appeal proceedings. It is only after the final decision has become legally binding that a filing of a withdrawal application is inadmissible. - With the closure of the proceedings, the impugned decision will become ineffective. KEYWORDS: Application to withdraw an action (R.265.1 RoP) APPELLANT (CLAIMANT AND COUNTERDEFENDANT BEFORE THE COURT OF FIRST INSTANCE) DexCom, Inc., San Diego, CA, USA (hereinafter ‘Dexcom‘) represented by: Anne-Charlotte Le Bihan, Attorney-at-law, and Laurent Labatte, European Patent Attorney (B ...